These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 31268205

  • 1. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.
    Liao XZ, Gao Y, Huang S, Chen ZZ, Sun LL, Liu JH, Chen HR, Yu L, Zhang JX, Lin LZ.
    Phytother Res; 2019 Sep; 33(9):2298-2309. PubMed ID: 31268205
    [Abstract] [Full Text] [Related]

  • 2. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J, Liu JH, Liu H, Liao XZ, Chen Y, Lin MG, Gu YY, Liu TL, Wang DM, Ge H, Mo SL.
    BMC Cancer; 2016 Nov 18; 16(1):899. PubMed ID: 27863471
    [Abstract] [Full Text] [Related]

  • 3. Tanshinone IIA inhibits proliferation and migration by downregulation of the PI3K/Akt pathway in small cell lung cancer cells.
    Jiang Y, Bi Y, Zhou L, Zheng S, Jian T, Chen J.
    BMC Complement Med Ther; 2024 Jan 31; 24(1):68. PubMed ID: 38297301
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway.
    Teng Z, Xu S, Lei Q.
    Oncol Rep; 2020 Feb 31; 43(2):503-515. PubMed ID: 31894340
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA derivatives induced S-phase arrest through stabilizing c-myc G-quadruplex DNA to regulate ROS-mediated PI3K/Akt/mTOR pathway.
    Wang T, Zou J, Wu Q, Wang R, Yuan CL, Shu J, Zhai BB, Huang XT, Liu NZ, Hua FY, Wang XC, Mei WJ.
    Eur J Pharmacol; 2021 Dec 05; 912():174586. PubMed ID: 34710368
    [Abstract] [Full Text] [Related]

  • 6. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
    Zhang YZ, Lai HL, Huang C, Jiang ZB, Yan HX, Wang XR, Xie C, Huang JM, Ren WK, Li JX, Zhai ZR, Yao XJ, Wu QB, Leung EL.
    Phytomedicine; 2024 Jun 05; 128():155431. PubMed ID: 38537440
    [Abstract] [Full Text] [Related]

  • 7. Reversal of cisplatin resistance by inhibiting PI3K/Akt signal pathway in human lung cancer cells.
    Zhang Y, Bao C, Mu Q, Chen J, Wang J, Mi Y, Sayari AJ, Chen Y, Guo M.
    Neoplasma; 2016 Jun 05; 63(3):362-70. PubMed ID: 26925782
    [Abstract] [Full Text] [Related]

  • 8. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, Yin L, Tang Y, Wang M, Ye L, Zhan Z, Duan J, Fu H, Zhang X.
    Integr Cancer Ther; 2014 Mar 05; 13(2):152-60. PubMed ID: 24105357
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway.
    Ye YT, Zhong W, Sun P, Wang D, Wang C, Hu LM, Qian JQ.
    J Ethnopharmacol; 2017 Mar 22; 200():107-116. PubMed ID: 28088493
    [Abstract] [Full Text] [Related]

  • 10. MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.
    Huang G, Lou T, Pan J, Ye Z, Yin Z, Li L, Cheng W, Cao Z.
    Aging (Albany NY); 2019 Apr 12; 11(7):2138-2150. PubMed ID: 30981205
    [Abstract] [Full Text] [Related]

  • 11. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N, Zhang X, Ma Z, Niu J, Ma S, Wenjie W, Chen J.
    Biomed Pharmacother; 2020 Mar 12; 123():109729. PubMed ID: 31887543
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
    Yang Y, Deng Y, Chen X, Zhang J, Chen Y, Li H, Wu Q, Yang Z, Zhang L, Liu B.
    Toxicol Lett; 2018 Oct 01; 295():88-98. PubMed ID: 29857117
    [Abstract] [Full Text] [Related]

  • 13. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway.
    Liu H, Liu C, Wang M, Sun D, Zhu P, Zhang P, Tan X, Shi G.
    Sci Rep; 2021 Sep 29; 11(1):19268. PubMed ID: 34588580
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
    Zhou J, Jiang YY, Chen H, Wu YC, Zhang L.
    Cell Prolif; 2020 Feb 29; 53(2):e12739. PubMed ID: 31820522
    [Abstract] [Full Text] [Related]

  • 15. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A, Li H, Li R, Lu L, Wu X.
    Oncol Rep; 2018 Oct 29; 40(4):2353-2362. PubMed ID: 30066933
    [Abstract] [Full Text] [Related]

  • 16. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ, Yang ZX, Dai XT, Chen YF, Yang HP, Zhou XD.
    Apoptosis; 2017 Sep 29; 22(9):1157-1168. PubMed ID: 28677094
    [Abstract] [Full Text] [Related]

  • 17. Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway.
    Chen SY, Zhang GC, Shu QJ.
    Pharm Biol; 2021 Dec 29; 59(1):1294-1304. PubMed ID: 34543169
    [Abstract] [Full Text] [Related]

  • 18. Tanshinone IIA alleviates acute ethanol-induced myocardial apoptosis mainly through inhibiting the expression of PDCD4 and activating the PI3K/Akt pathway.
    Deng H, Yu B, Li Y.
    Phytother Res; 2021 Aug 29; 35(8):4309-4323. PubMed ID: 34169595
    [Abstract] [Full Text] [Related]

  • 19. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
    Jiao JW, Wen F.
    Oncol Rep; 2011 Mar 29; 25(3):781-8. PubMed ID: 21165580
    [Abstract] [Full Text] [Related]

  • 20. [Tanshinone IIA alleviates monocrotaline-induced pulmonary hypertension in rats through the PI3K/Akt-eNOS signaling pathway].
    Zhang X, Liu S, Sun Y, Li G.
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May 20; 42(5):718-723. PubMed ID: 35673916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.